Pharmaceutical
ChemLinkedMarketChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
INDUSTRY
Law & Regulation Guideline Pharmacopoeia Reference Listed Drug (RLD) OTC Drug
Monthly Recap: China Pharmaceutical Regulatory Updates | August 2023 China pharma regulatory updates in Aug 2023: 1. China Consults on Conditional Approval Process; 2. China Rolls out 71st and 72nd Lists of RLDs; 3. China Grants Two Rx-to-OTC Switches; 4. China Releases Pharmaceutical Guidelines; 5. China Consults on Drafts of Drug Standards
Sep 08, 2023
INDUSTRY
Marketing Approval Innovative Drug Generic Drug Biological Product Drug Registration New Drug
Monthly Report: New Drug Approvals in China | August 2023 In Aug. 2023, China NMPA approved 17 new drugs, among which 14 are chemical drugs and 3 are biological products.
Sep 07, 2023
INDUSTRY
Marketing Approval Innovative Drug Diabetes Drug Registration New Drug
[Updated] GLP-1-RAs Swoop to Chinese Market, Eyeing Diabetes Treatment & Weight Control Needs On July 25, 2023, China National Medical Products Administration (NMPA) approved Beinaglutide Injection (Feisumei), a glucagon-like peptide-1 receptor agonist (GLP-1-RA), for weight loss.
Aug 23, 2023
INDUSTRY
Marketing Approval Priority Review Generic Drug Diabetes Drug Registration New Drug
Monthly Report: New Drug Approvals in China | July 2023 In July 2023, China NMPA approved 5 new drugs, among which 3 are chemical drugs and 2 are biological products.
Aug 03, 2023
INDUSTRY
Marketing Approval Priority Review Innovative Drug Generic Drug Biological Product Cancer Diabetes Drug Registration New Drug
Monthly Report: New Drug Approvals in China | June 2023 In June 2023, China NMPA approved 33 new drugs, among which 26 are chemical drugs while 7 are biological products.
Jul 07, 2023
INDUSTRY
Guideline CMC
BaiPharm Shares Insights into Computational Toxicology with Pharma Professionals at CPHI China As CPHI China’s partner, BaiPharm staged a seminar “Application of Computational Toxicology in the Pharmaceutical Industry” which covers four sessions, each presented by experienced experts, on June 19, 2023.
Jun 25, 2023
INDUSTRY
Marketing Approval Innovative Drug Generic Drug Biological Product Cancer Diabetes Vaccine Drug Registration New Drug
Monthly Report: New Drug Approvals in China | May 2023 In May 2023, China NMPA approved 27 new drugs, among which 16 are chemicals and 11 are biologics: 1. Betta Pharma’ Befotertinib Mesylate Capsules; 2. Sanhome Pharma’s Alfosbuvir Tablets; 3. Novartis’ Ribociclib Succinate Tablets...
Jun 12, 2023
INDUSTRY
Clinical Trial CRO
China Contract Research Organization (CRO) Industry 2022 Review China’s CROs are developing rapidly, partly demonstrated by its rising revenue. Three China-based CROs—Wuxi AppTec, Pharmaron, and TigerMed—are ranked among the top 10 CROs in terms of 2022’s revenue.
Jun 01, 2023
INDUSTRY
Marketing Approval Innovative Drug Generic Drug Biological Product Cancer Drug Registration
Monthly Report: New Drug Approvals in China | April 2023 In Apr. 2023, China NMPA approved 13 new drugs, among which 11 are chemical drugs while 2 are biological products.
May 10, 2023
INDUSTRY
Law & Regulation
Green Development: Not Merely Conceptual, But Compulsory for Pharma Manufacturing in China China is not advanced enough in regulations and technologies for green development, but the good news is that China has been making progress. China tends to turn guidelines into compulsory regulations, including setting up clearer standards for regulating pollution emission.
Apr 19, 2023
12345 ...7 Next
Most Popular